Structures by: Al-Abdullah E. S.
Total: 11
3-(Adamantan-1-yl)-4-phenyl-1-[(4-phenylpiperazin-1-yl)methyl]- 1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C29H35N5S
Acta Crystallographica Section E (2012) 68, 2 o345
a=11.3342(5)Å b=8.4744(3)Å c=13.7868(6)Å
α=90.00° β=103.864(4)° γ=90.00°
Ethyl 4-{[3-(adamantan-1-yl)-4-phenyl-5-sulfanylidene-4,5-dihydro-1<i>H</i>- 1,2,4-triazol-1-yl]methyl}piperazine-1-carboxylate
C26H35N5O2S
Acta Crystallographica Section E (2012) 68, 2 o531
a=12.0469(6)Å b=20.9213(10)Å c=10.3249(5)Å
α=90.00° β=109.851(6)° γ=90.00°
3-(Adamantan-1-yl)-1-[(4-benzylpiperazin-1-yl)methyl]-4-phenyl- 1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C30H37N5S
Acta Crystallographica Section E (2012) 68, 2 o344
a=10.1677(6)Å b=11.3287(7)Å c=12.5331(7)Å
α=67.037(6)° β=85.768(5)° γ=83.547(5)°
3-(Adamantan-1-yl)-4-[(<i>E</i>)-(2,6-difluorobenzylidene)amino]-1-[(4- phenylpiperazin-1-yl)methyl]-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C30H34F2N6S
Acta Crystallographica Section E (2012) 68, 7 o2031
a=17.2712(3)Å b=7.71410(10)Å c=21.3157(4)Å
α=90.00° β=95.245(2)° γ=90.00°
5-(Adamantan-1-yl)-3-[(2-methoxyethyl)sulfanyl]-4-phenyl-4<i>H</i>-1,2,4-triazole
C21H27N3OS
Acta Crystallographica Section E (2012) 68, 8 o2326
a=22.5107(5)Å b=9.7642(2)Å c=19.5594(3)Å
α=90.00° β=116.6790(10)° γ=90.00°
5-(Adamantan-1-yl)-3-(benzylsulfanyl)-4-methyl-4<i>H</i>-1,2,4-triazole
C20H25N3S
Acta Crystallographica Section E (2012) 68, 8 o2427-o2428
a=6.4554(3)Å b=14.0258(6)Å c=20.2264(9)Å
α=94.610(2)° β=95.568(3)° γ=98.317(3)°
3-(Adamantan-1-yl)-4-ethyl-1-[(4-phenylpiperazin-1-yl)methyl]-1<i>H</i>-1,2,4- triazole-5(4<i>H</i>)-thione
C25H35N5S1
Acta Crystallographica Section E (2012) 68, 8 o2380-o2381
a=27.382(4)Å b=6.5083(7)Å c=13.369(2)Å
α=90.00° β=90.00° γ=90.00°
3-(Adamantan-1-yl)-4-ethyl-1-{[4-(2-methoxyphenyl)piperazin-1-yl]methyl}-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C26H37N5OS
Acta Crystallographica Section E (2014) 70, 1 o25-o26
a=19.8170(3)Å b=11.9384(3)Å c=21.7807(4)Å
α=90.00° β=107.886(2)° γ=90.00°
3-(Adamantan-1-yl)-4-[(<i>E</i>)-(2,6-difluorobenzylidene)amino]-1-[(4-ethylpiperazin-1-yl)methyl]-4,5-dihydro-1<i>H</i>-1,2,4-triazole-5-thione
C26H34F2N6S
Acta Crystallographica Section E (2013) 69, 5 o685-o686
a=17.0824(11)Å b=7.8212(6)Å c=19.6691(14)Å
α=90.00° β=92.249(6)° γ=90.00°
3-(Adamantan-1-yl)-1-[(4-benzylpiperazin-1-yl)methyl]-4-ethyl-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C26H37N5S
Acta Crystallographica Section E (2013) 69, 12 o1813-o1814
a=10.5618(2)Å b=11.2123(2)Å c=11.3084(2)Å
α=89.9740(10)° β=77.6190(10)° γ=70.8420(10)°
<i>N</i>-(Adamantan-1-yl)-1,2,3,4-tetrahydroisoquinoline-2-carbothioamide
C20H26N2S
Acta Crystallographica Section E (2013) 69, 12 o1815
a=19.1707(5)Å b=6.4106(2)Å c=14.2838(3)Å
α=90.00° β=103.366(2)° γ=90.00°